Vanta Bioscience inks CRO agreement with Emcure Pharmaceuticals

06 Apr 2019 Evaluate

Vanta Bioscience through its step down subsidiary -- Vayam Research Solutions has entered into a non-exclusive CRO Service Agreement with Emcure Pharmaceuticals, Pune, for providing services of Bio-Analytical and Bio-Equivalence services to the said company for a period of three years from 2019 to 2022.

The CRO Service Agreement provides for a minimum revenue assurance between Rs 7 crore to Rs 9 crore for the financial year 2019-2020 and Rs 20 crore for financial year 2020-2021.

Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.


Vanta Bioscience Share Price

50.33 1.35 (2.76%)
28-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 915.70
Sagility India 34.94
AGS Transact Tech 79.93
Just Dial 1119.55
Krystal Integrated 769.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.